短期肺功能趋势可预测系统性硬化相关间质性肺病死亡率
本研究评估系统性硬化相关间质性肺病(SSc-ILD)患者1年和2年肺功能测试(PFT)趋势对15年生存的预后价值。结果显示,在广泛肺纤维化患者中,1年FVC分类变化(单独或联合DLco分类变化)对死亡率有预测价值;2年时气体转移趋势在全队列和局限肺纤维化患者中预后意义最大。FVC和DLco复合终点(FVC下降≥10%或FVC下降5-9%联合DLco下降≥15%)为试验用最佳进展定义。
要点
- 广泛肺纤维化患者1年FVC分类变化(单独或联合DLco)可预测死亡率。
- 2年气体转移趋势在全队列和局限肺纤维化患者中预后意义最大。
- FVC下降≥10%或FVC下降5-9%联合DLco下降≥15%为试验用最佳进展定义。
核心结论
- 在SSc-ILD患者中,短期PFT趋势与长期生存相关,支持常规肺功能监测。
- FVC和DLco复合终点值得在临床试验中进一步评估。
研究设计与样本
- 回顾性队列分析,评估1年(n=162)和2年(n=140)PFT趋势与15年生存的关系。
- SSc-ILD在初诊时按英国Raynaud's和Scleroderma Association严重度分期系统分为局限肺纤维化和广泛肺纤维化。
- PFT趋势以连续变化和分类变化分别进行单变量和多变量分析。
主要发现
- 1年PFT趋势仅在广泛肺纤维化患者中预测死亡率,FVC分类变化(单独或联合DLco分类变化)预后意义大于FVC连续变化或其他PFT变量趋势。
- 2年时气体转移趋势在全队列和局限肺纤维化患者中预后意义最大。
- 在广泛肺纤维化患者中,上述FVC和DLco复合终点是最强的预后决定因素。
- FVC:DLco比值变化需大于一氧化碳转移系数变化才能达到预后意义。
关键数值与推荐
- 试验用最佳进展定义:FVC较基线下降≥10%,或FVC下降5-9%联合DLco下降≥15%。
临床怎么用
- 对SSc-ILD患者应常规进行肺量计和气体转移监测。
- 在广泛肺纤维化患者中,关注1年FVC分类变化及FVC与DLco复合变化。
- 在局限肺纤维化患者中,关注2年气体转移趋势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the prognostic value of pulmonary function test (PFT) trends at 1 and 2 years in interstitial lung disease (ILD) associated with systemic sclerosis (SSc). METHODS: The prognostic significance of PFT trends at 1 year (n = 162) and 2 years (n = 140) was examined against 15-year survival in patients with SSc-associated ILD. PFT trends, expressed as continuous change and as categorical change in separate analyses, were examined against mortality in univariate and multivariate models. SSc-associated ILD was defined at presentation as either limited lung fibrosis or extensive lung fibrosis, using the United Kingdom Raynaud's and Scleroderma Association severity staging system. RESULTS: One-year PFT trends were predictive of mortality only in patients with extensive lung fibrosis: categorical change in the forced vital capacity (FVC), alone or in combination with categorical change in the diffusing capacity for carbon monoxide (DLco), had greater prognostic significance than continuous change in the FVC or trends in other PFT variables. Taking into account both prognostic value and sensitivity to change, the optimal definition of progression for trial purposes was an FVC and DLco composite end point, consisting of either an FVC decline from baseline of ≥10% or an FVC decline of 5-9% in association with a DLco decline of ≥15%. At 2 years, gas transfer trends had the greatest prognostic significance, in the whole cohort and in those with limited lung fibrosis. However, in patients with extensive lung fibrosis, the above-defined FVC and DLco composite end point was the strongest prognostic determinant. Larger changes in the FVC:DLco ratio than in the carbon monoxide transfer coefficient were required to achieve prognostic significance. CONCLUSION: Based on linkages to long-term outcomes, these findings provide support for use of routine spirometry and gas transfer monitoring in patients with SSc-associated ILD, with further evaluation of a composite FVC and DLco end point warranted for trial purposes.
引用
- Goh NS, Hoyles RK, Denton CP, et al. Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis. Arthritis Rheumatol. 2017. PMID: 28426895. doi:10.1002/art.40130
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。